<DOC>
	<DOC>NCT00522275</DOC>
	<brief_summary>The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy</brief_summary>
	<brief_title>Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Completion of parent clinical trial for treatment of partial seizures Receiving any study drug or experimental device other than lacosamide Meets withdrawal criteria for parent trial or experiencing ongoing serious adverse event</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Adjunctive treatment in epilepsy</keyword>
	<keyword>add-on treatment for epilepsy</keyword>
	<keyword>partial seizures</keyword>
	<keyword>AEDs</keyword>
	<keyword>antiepileptic drugs</keyword>
	<keyword>seizures</keyword>
</DOC>